Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-01-17 09:57:28

expired found date

-

created at

2024-06-19 06:42:34

updated at

2026-02-21 06:54:07

Domain name statistics

length

14

crc

17068

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

173561409

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

23662

mp size raw text

3076

mp inner links count

6

mp inner links status

20 (imported)

Open Graph

title

Neuralstem, Inc. (CUR)

description

site name

Neuralstem, Inc.

author

updated

2025-12-29 06:28:40

raw text

Neuralstem, Inc. (CUR) Home About Overview Management Team Board of Directors Platform Publications and Presentations Pipeline Overview NSI-189 NSI-566 News & Media Press Releases Presentations Events Investors Overview News / Events Company Information Financial Information Stock Data SEC Filings Corporate Governance Contact Innovating Nervous System Therapies Neuralstem (NASDAQ: CUR) is a biopharmaceutical company researching and developing novel treatments for nervous system diseases based on our neural stem cell technology. About us Our Lead Asset NSI-189 is a new chemical entity in clinical development for major depressive disorder (MDD) and in preclinical development for Angelman syndrome, cognitive impairment, neuropathy associated with Type 1 and Type 2 diabetes, and stroke. Our Pipeline Clinical Programs We currently have two clinical development programs: The NSI-189 small molecule program and the NSI-566 stem ce...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medicine [en] (226)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2355

text words

427

text unique words

162

text lines

123

text sentences

9

text paragraphs

2

text words per sentence

47

text matched phrases

11

text matched dictionaries

4

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)

sitemap review version

2

sitemap urls count

8

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-01-17 09:57:28

sitemap process date

2024-10-21 02:29:06

sitemap first import date

-

sitemap last import date

2026-02-21 06:54:07